Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Morag on +44 1494 818 018 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Morag Shea
Scotland Manager
+44 1494 818 018

From first conversation right through to negotiations I would summarise your involvement in the process as (i) highly professional (ii) consultative and (iii) thoroughly supportive.
Ben , 2013

Sigma-Aldrich and King's College London agree miRNA collaboration

9 May 2011 00:00 in Scientific Company News

Sigma-Aldrich is allying with King's College London on new research into miRNA (micro RNA) identification technology for use in clinical diagnostics.

The firm's Sigma Life Science division has agreed a licensing deal with the college to develop and commercialise new technology for isolating and validating miRNA targets, a process that is currently difficult and inefficient.

It will focus on a new innovation from King's that simplifies this step, allowing key gene regulation events to be elucidated in vivo.

Both Sigma-Aldrich and King's expect the development of this technology to offer benefits in oncology research, as many miRNAs function as oncogenes or tumour suppressor genes.

Steven Suchyta, market segment manager at Sigma-Aldrich, said: "We believe that the exclusive license agreement will allow Sigma Life Science and King's College London to work closely together to ensure rapid development of this technology for the benefit of the research community."

Last month, the company published its financial report for the first three months of 2011, during which it delivered a new record level of quarterly sales.ADNFCR-8000103-ID-800524216-ADNFCR

Other news stories from 09/05/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd